Well, as the old lady from the Wendy's commercial used to say: "Where's the Beef?"
What exactly is prompting you to post with a new handle?
I don't remember seeing "you" here before...at least not in this "incarnation."
Any insight as to the possible resolution of the legal issues (don;t forget, there are two, though somewhat related, I guess).
So, let me get this straight.
A Vancouver, BC company with a drug to combat ebola gives a #$%$ about what the FDA has to say about the use of their drug in places like Liberia? Why?
The fact that they have the highest prices tolerable means that management is doing a pretty good job.
$295 - 20/share "excess cash/investments" = $275 net price
Estimated '14 earnings: $14.50
20x earnings would be $289. so we are about 19.5x estimated earnings for 2014.
he is including the $10 million that is classified as LT Investments, which is simply an accounting convention for bonds held with a maturity of more than one year at time of purchase.
PLNR released its earnings much earlier than usual.
Working back from 2013, the report date has been 8/8, 8./13, 8/11, and ok, 7/29 in 2010, 8/4.
So why did the earnings report date get moved up this year?
Here's my guess:
Management knew that this particular earnings report was going to blow the roof off the stock.
It also appears that CEO Gerald Perkel was scheduled to get a grant of 41,221 free shares at the 7/31 closing price date. So, he got the 41,221 shares at $2.69 as of 7/31 according to a company SEC filing (a Form 4).
Earnings come out, and boom, talk about IMMEDIATE GRATIFICATION. An extra $40,000 for Mr. CEO.
This is slimy, at best.
So, with the share count down to 91 million, the current market cap is only around $4.5 billion.
Considering that 2014 FCF (that's CFO less capex) will be in the $600 million range, that's a sweet 13% FCF yield.
Also, the SEC took no action against Usana. This move has, IMHO, been all about sympathy with NUS over the past week or so, along with the slight slowdown in US results.
The great thing about the market is it is like being a batter in baseball where they keep on serving up an unlimited number of pitches and you can pick the best ones. As long as you don't strike out (i.e. go broke), you keep hitting. And, as in baseball, lots of singles and doubles work great, while the occasional triple or home run is like icing ion the cake.
This contract could be worth as much as $810 million (to both SPA and Ultra) over 5 years.
Is this a much larger annual pace of purchasing than in the past?
The FCF yield here is currently over 10%. It is difficult for me to understand why it got so low last year, but as a $10 stock, it is volatile, not stable.
Thinking about selling $10 puts at some point.
Share count is down 6.2% YoY in 15FQ1.
I am concerned that the share repurchases are simply going to executives through massive option/stock grants and will do some work on that.
I've known the company for many, many years and they are a survivor in a market that still is growing.
What does this have to do with Yahoo?
The reality is, you have a debt-free company with visibility a year out to on the order of $0.30/share of e.p.s. with a 13 multiple on that number.
Given hat a division with close to half the company's revenue has been growing in the 25%-45% range for multiple consecutive quarters, and a P/E of 15-20x seems very reasonable to me.
I have sold a slug of my position here this week, simply because, as a trader, that's what you do when you have a huge profit.
If it pulls back substantially (say, under $3), I could reload some.
The CFO seemed to be FAR in excess of the dividend need.
Still, looks pretty messed up compared to where we were 10 years ago.
Isn't this ETF relatively easy to replicate on your own if you know the members?
How is it weighted? Equally?
is it an active fund within a pre-set universe of "S&P Aristocrats"
I guess I'll actually have to do some DD.
As Ed McMahon frequently replied to Johnny Carson: "You are correct, SIR!"
The digital signage business has been growing rapidly for some time.
They have finally reached the crossover of revenue in that growing segment relative to revenue in the rest of the business.
At the same time, they are starting to see some margin benefit from operating leverage in the growing business to offset the shrinking margins in the rest of the business.
I started shrinking my position yesterday and continued today. My position has been reduced by about 1/3 in size, but I have taken out about 75% of the total amount I had invested.
Good luck to you!